Delivery Order SPE2DB24D2205-SPE2DB25FEBWK
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a ceiling value of $18,756.29 and a period of performance through February 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The award, valued at $5,893.91, is a firm fixed-price contract with an ultimate completion date of April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,597.58 fixed-price contract is for the supply of a single medical product, MONOVISC 88 MG/4 ML SYRINGE 4ML, with a period of performance through July 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December 2025, for...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a ceiling value of $10,891.64 and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distributor, is delivering these medical supplies to support military treatment programs and facilities through a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, at a ceiling value of $4,905.57. The contract has an ultimate completion date of May 9, 2023 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a Ceiling Value of $6,622.24. The contract is for a Firm Fixed Price and has an Ultimate Completion Date of March 31, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a ceiling value of $8,362.97 and a completion date of February 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,529.38 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a ceiling value of $1,979.24 and a period of performance through May 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,865.61 firm fixed price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, to support federal healthcare programs. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...